Technology News and Research

RSS

NIH awards QuantaLife $6 million to build platform for detecting MRSA infections

QuantaLife, a new life science tool company developing the third generation of PCR, has received an NIH grant totaling ~$6 million over 5 years for the development of rapid, cost-effective technology for detecting methicillin-resistant Staphylococcus aureus (MRSA) infections. The grant, from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), part of the National Institutes of Health, will fund the project.

14 Sep 2010

Transgenomic expands EU distribution of SURVEYOR Scan K-RAS CE IVD mutation detection kit

Transgenomic, Inc. today announced that it completed the requirements for CE IVD labeling and has significantly expanded distribution of its SURVEYOR® Scan K-RAS mutation detection kit throughout most of the European Union. The SURVEYOR Scan K-RAS CE IVD kit is a member of Transgenomic's family of mutation detection kits, which features proprietary SURVEYOR endonuclease technology.

14 Sep 2010

AskBio enters patent license agreement with Pfizer for HCV therapy

Asklepios BioPharmaceutical, Inc., a privately-owned clinical-stage biotechnology company, announced today it has entered into a patent license agreement with Pfizer, Inc. granting Pfizer access to certain proprietary gene-delivery platform technologies developed by AskBio, for use in developing novel therapies for patients with Hepatitis C virus (HCV).

14 Sep 2010

St. John Hospital commences enrollment in CONNECT trial for peripheral artery disease

St. John Hospital and Medical Center in Detroit and Avinger, Inc., a medical device company focused on the development of innovative devices to combat peripheral artery disease, announced today the enrollment of the first patient in the CONNECT (Chronic TOtal OcclusioN CrossiNg with thE WildCat CatheTer) clinical trial.

14 Sep 2010

AstraZeneca, UCL collaborate to identify new therapeutic tools to modulate regenerative capacity of stem cells

AstraZeneca and UCL (University College London) today announced that they have entered into a collaboration to develop regenerative medicines for diabetic retinopathy (DR).

13 Sep 2010

Health care expected to help fuel job growth yet new nurses having difficulties finding jobs

Orlando Sentinel: "Thousands more health-care workers, from doctors to nurses to physical therapists, will be needed in the coming decade in Florida and across the country to treat the increasing number of older Americans — particularly the enormous baby boom generation. According to the U.S. Bureau of Labor Statistics, health care is expected to generate 3.2 million new jobs through 2018, more than any other industry and mainly because of the increasing number of elderly.

13 Sep 2010

HealthWyse, Cardiocom partner to integrate patient information into clinical software

HealthWyse, a leading provider of home health and hospice software and services, announced today that it has partnered with Cardiocom, a leader in home telehealth solutions, to seamlessly integrate patient information into HealthWyse's clinical software.

13 Sep 2010

Acsis recognized as 2010 'Top Preferred Solution Provider' by LogiPharma

Acsis, Inc., a leader in supply chain visibility and traceability for manufacturing and distribution, today announced that it has been recognized as a 2010 "Top Preferred Solution Provider" by LogiPharma. The company was selected based on a survey by World Business Research (WBR) to more than 2,000 pharmaceutical executives who identified Acsis, Inc. as one of the top solution providers focused on advancing supply chain efficiencies.

13 Sep 2010

Independence Blue Cross of Pennsylvania deploys Infoblox appliances with network services suite

Infoblox Inc. today announced that Independence Blue Cross of Pennsylvania has selected and deployed Infoblox appliances to deliver highly reliable and manageable domain name system (DNS), IP address assignment (DHCP) and IP address management (IPAM) services. Independence Blue Cross is Philadelphia's largest healthcare insurer with 2.4 million members locally and 3.3 million nationwide.

13 Sep 2010

Today's Opinions: Prevention and small business; Views on medical inflation and health reform; Sebelius letter examined

In this anemic economy, small businesses need all the help they can get, and the Prevention and Public Health Fund provides the best medicine (Dr. Georges Benjamin and Larry Cohen, 9/13).

13 Sep 2010

Kadlec integrates Medi-Span clinical decision support system with Epic EMR

Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Kadlec Regional Medical Center will deploy Medi-Span® to provide clinicians with point-of-care access to comprehensive drug information and medication decision support via the facility's EMR system.

13 Sep 2010

Counterfeit drugs become growing problem

"Last year, nearly 1,700 incidents of counterfeit drugs were reported worldwide, triple the number in 2004, says the Pharmaceutical Security Institute (PSI), a group funded by drugmakers," USA Today reports. "Estimates for the size of the counterfeit drug market range from $75 billion to $200 billion a year. The market is likely much bigger because many cases are hard to detect.

13 Sep 2010

Merit Medical Systems acquires BioSphere Medical

Merit Medical Systems, Inc. today announced the completion of its acquisition of BioSphere Medical, Inc., a leading developer and marketer of embolotherapeutic products for the treatment of uterine fibroids, hypervascularized tumors, and arteriovenous malformations.

13 Sep 2010

Genomas awarded method patent for PhyzioGenomics Technology

Genomas®, a biomedical company advancing DNA-Guided Medicine, has been awarded US Patent 7,747,392, entitled Physiogenomic Method for Predicting Clinical Outcomes of Treatment in Patients by the US Patent and Trademark Office.

13 Sep 2010

World's first reusable bio-chip for SNP genotyping market

Fluidigm Corporation today introduced its reusable FR48.48 Dynamic Array™ integrated fluidic circuit (IFC) - the world's first reusable bio-chip for the SNP genotyping market. This chip begins a new era of ultra-low cost, high sample throughput SNP genotyping and marks the beginning of Fluidigm's drive toward one-penny-per-data point.

13 Sep 2010

Orion extends use of Medidata Rave enterprise-wide EDC and clinical data management system

Medidata Solutions, a leading global provider of SaaS-based clinical development solutions, today announced that European pharmaceutical company Orion has extended its use of Medidata Rave® as its enterprise-wide electronic data capture (EDC) and clinical data management (CDM) system, which Orion successfully brought in-house and deployed for all clinical trials for the past three and a half years.

13 Sep 2010

NIH awards PhysioNetics $815,000 for development of low-cost prosthetic interface

ADA Technologies, Inc.'s PhysioNetics division has been awarded an $815,000 grant from the National Institutes of Health, National Institute of Child Health and Human Development. The Phase II award will enable PhysioNetics to complete design refinements and commercialization activities for its low-cost upper-extremity prosthetic interface, also known as a "socket."

13 Sep 2010

Relypsa completes $70M Series B financing

Relypsa, Inc., a biopharmaceutical company developing non-absorbed polymeric drugs, today announced the completion of a Series B financing totaling $70 million. OrbiMed Advisors, LLC, led the financing with participation from existing Relypsa investors New Leaf Venture Partners, 5AM Ventures, Delphi Ventures, Sprout Group and Mediphase Venture Partners.

13 Sep 2010

Keais Records Service launches new online portal

Keais Records Service, established in 1975 as the first litigation support company specializing in records retrieval services, is celebrating its milestone thirty-fifth anniversary by launching a new web site and further enhancing its electronic capabilities to serve the litigation discovery needs of major law firms, insurance companies, corporations and TPAs.

13 Sep 2010

AB SCIEX, University of Melbourne join to develop drug metabolism studies of biopharmaceuticals

AB SCIEX, a global leader in life science analytical technologies, and the University of Melbourne today announced a joint technology development project to improve drug metabolism studies of biopharmaceuticals.

13 Sep 2010

Technology News and Research

NIH awards QuantaLife $6 million to build platform for detecting MRSA infections

Transgenomic expands EU distribution of SURVEYOR Scan K-RAS CE IVD mutation detection kit

AskBio enters patent license agreement with Pfizer for HCV therapy

St. John Hospital commences enrollment in CONNECT trial for peripheral artery disease

AstraZeneca, UCL collaborate to identify new therapeutic tools to modulate regenerative capacity of stem cells

Health care expected to help fuel job growth yet new nurses having difficulties finding jobs

HealthWyse, Cardiocom partner to integrate patient information into clinical software

Acsis recognized as 2010 'Top Preferred Solution Provider' by LogiPharma

Independence Blue Cross of Pennsylvania deploys Infoblox appliances with network services suite

Today's Opinions: Prevention and small business; Views on medical inflation and health reform; Sebelius letter examined

Kadlec integrates Medi-Span clinical decision support system with Epic EMR

Counterfeit drugs become growing problem

Merit Medical Systems acquires BioSphere Medical

Genomas awarded method patent for PhyzioGenomics Technology

World's first reusable bio-chip for SNP genotyping market

Orion extends use of Medidata Rave enterprise-wide EDC and clinical data management system

NIH awards PhysioNetics $815,000 for development of low-cost prosthetic interface

Relypsa completes $70M Series B financing

Keais Records Service launches new online portal

AB SCIEX, University of Melbourne join to develop drug metabolism studies of biopharmaceuticals

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News